作者:
Justyna M,Przystal [1]
;
Hannes,Becker [2]
;
Denis,Canjuga [1]
;
Foteini,Tsiami [2]
;
Nicole,Anderle [1]
;
Anna-Lena,Keller [1]
;
Anja,Pohl [2]
;
Carola H,Ries [3]
;
Martina,Schmittnaegel [3]
;
Nataliya,Korinetska [3]
;
Marilin,Koch [4]
;
Jens,Schittenhelm [4]
;
Marcos,Tatagiba [1]
;
Christian,Schmees [1]
;
Susanne C,Beck [2]
;
Ghazaleh,Tabatabai [5]
作者单位:
Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
[1]
German Translational Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, 72076 Tübingen, Germany.
[2]
NMI, Natural and Medical Sciences Institute, University of Tübingen, 72770 Reutlingen, Germany.
[3]
Roche Innovation Center Munich, Oncology Division, Roche Pharmaceutical Research and Early Development, 82377 Penzberg, Germany.
[4]
Institute for Neuropathology, University Hospital Tübingen, 72076 Tübingen, Germany.
[5]
Department of Neurosurgery, University Hospital Tübingen, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
[6]
Cluster of Excellence iFIT (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
[7]
DOI
10.3390/cancers13102400
PMID
34063518
发布时间
2021-06-05